-
June 14, 2007 Lupin receives Final FDA Approval for Trandolapril
-
May 31, 2007 Lupin Receives US FDA Approval for Cefadroxil Capsules
-
May 31, 2007 Lupin and Symbiotec decide not to pursue their MoU
-
May 21, 2007 Lupin receives tentative US FDA Approval for Ziprasidone
-
May 15, 2007 Lupin Receives US FDA Approval for Simvastatin Tablets
-
April 27, 2007 DST and Lupin join hands over Migraine and Psoriasis
-
April 12, 2007 Lupin receives US FDA Approval for Novel Formulation of Suprax® Suspension
-
February 20, 2007 Lupin sells Intellectual Property on Perindopril to Servier
-
February 7, 2007 Lupin receives US FDA approval for Sertraline
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications